Cohen Veterans Bioscience announced its strategic collaboration with Parexel Biotech, a new division of Parexel, for CVB’s adaptive platform trial evaluating pharmacotherapeutics to treat PTSD. Cohen Veterans Bioscience would like to honor our military veterans by highlighting the ways we are transforming science to advance brain health.RECENT NEWS
GET UPDATES
Help us fast-track diagnostics and treatments for Post-Traumatic Stress Disorder (PTSD) & Traumatic Brain Injury (TBI).
We Need Precision Medicine for The Brain
We bring together the brightest minds and deploy the most innovative scientific tools with an emphasis on scale, risk-minimization, efficiency and speed.
Recent Highlights
News
Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics
Events
Driving Progress on Veterans Brain Health
Donate Now
